Stephanie W Cheng, MD
Family Practice · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 2
- Since medical school
- 14 years
- Oregon Health Sciences University School of Medicine, 2012
Offices
2 locations · University of California San Francisco · UCSF Medical Group Business Services
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cheng’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A128591 · Current
Licensed to practise in California · since 2014 · expires 2027-05-31 · Oregon Health Sciences University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
- American Board of Family Medicine - Hospice and Palliative Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Original Medicare doctor bills
$61,285
Medicare paid this office $61,285 for 112 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 78 | $35,011 | $127 |
| Long return visit (40+ min) | 22 | $6,718 | $129 |
| New patient visit (60+ min) | 31 | $4,997 | $161 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 63 | $3,690 | $15 |
| New patient visit (60+ min) | 15 | $2,418 | $161 |
See all 8 services
| Long return visit (40+ min) | 78 | $35,011 | $127 |
| Long return visit (40+ min) | 22 | $6,718 | $129 |
| New patient visit (60+ min) | 31 | $4,997 | $161 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 63 | $3,690 | $15 |
| New patient visit (60+ min) | 15 | $2,418 | $161 |
| Advance care planning, first 30 minutes | 18 | $2,367 | $66 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 32 | $2,171 | $27 |
| Return visit (30+ min) | 11 | $1,038 | $87 |
Who their Medicare patients are
112 Original Medicare patients in 2024. Average age 71 · Women 71% · Also on Medicaid 21% · Health risk score 2.77. Sicker patients than 9 in 10 peers; the typical family practice clinician is at 1.13.
Conditions among them: Cancer 69% · High blood pressure 61% · Depression 39% · Chronic kidney disease 21% · Coronary heart disease 18% · Diabetes 17% · COPD 17% · Atrial fibrillation 15% · Stroke 12%.
The office billed $378,999, Medicare allowed $77,858 and paid $61,285; for 796 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 112 | 796 | 71 | 2.77 | $378,999 | $61,285 |
| 2023 | 77 | 610 | 69 | 2.70 | $285,888 | $46,791 |
| 2022 | 71 | 383 | 68 | 2.44 | $181,122 | $29,016 |
| 2021 | 40 | 251 | 68 | 2.58 | $111,317 | $18,259 |
| 2020 | 44 | 223 | 68 | 2.41 | $162,560 | $22,368 |
| 2019 | 17 | 61 | 63 | 3.28 | $42,245 | $6,273 |
| 2017 | 72 | 221 | 72 | 3.25 | $135,460 | $23,392 |
| 2016 | 32 | 78 | 71 | 2.45 | $54,526 | $9,256 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Long return visit (40+ min) | 56 | $30,213 | $127 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 63 | $8,533 | $28 |
| New patient visit (60+ min) | 31 | $5,029 | $162 |
| Advance care planning, first 30 minutes | 14 | $1,156 | $68 |
2022: 5 services
| Long return visit (40+ min) | 51 | $13,847 | $125 |
| New patient visit (60+ min) | 32 | $5,225 | $163 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 49 | $4,807 | $28 |
| Return visit (30+ min) | 17 | $2,533 | $87 |
| Advance care planning, first 30 minutes | 14 | $1,451 | $69 |
2021: 3 services
| Long return visit (40+ min) | 32 | $10,964 | $125 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 30 | $3,737 | $28 |
| New patient visit (60+ min) | 13 | $2,162 | $166 |
2020: 4 services
| Long return visit (40+ min) | 35 | $14,268 | $99 |
| Extended patient service without direct patient contact, first hour | 14 | $2,143 | $102 |
| Extended office or other outpatient service, first hour | 13 | $2,032 | $107 |
| New patient visit (60+ min) | 13 | $1,980 | $152 |
2017: 5 services
| Long return visit (40+ min) | 19 | $4,174 | $97 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 16 | $3,896 | $108 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 17 | $3,791 | $146 |
| Advance care planning, first 30 minutes | 15 | $1,750 | $73 |
| New patient visit (60+ min) | 11 | $1,650 | $150 |
2016: 1 service
| New patient visit (60+ min) | 16 | $2,412 | $151 |
Medicaid work
$4,212 in 2023
Medicaid paid $4,212 for 27 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 27 | $4,212 |
| 2023 | 27 | 1 | 13 | $4,212 |
Drugs they prescribed that Part D paid
$45,066
Pharmacies billed $45,066 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 49% of their Part D prescriptions (321 of 653) in 2024. A higher opioid share than 9 in 10 peers; the typical family practice clinician is at 2%. Long-acting opioids: 53% of their opioid prescriptions.
623 generic and 30 brand-name prescriptions · $45,066 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine | 49 | $13,796 | $282 |
| Fentanyl | 45 | $6,853 | $152 |
| Oxycodone | 91 | $3,997 | $44 |
| Duloxetine | 15 | $3,733 | $249 |
| Gabapentin | 72 | $1,076 | $15 |
See all 17 drugs
| Buprenorphine | 49 | $13,796 | $282 |
| Fentanyl | 45 | $6,853 | $152 |
| Oxycodone | 91 | $3,997 | $44 |
| Duloxetine | 15 | $3,733 | $249 |
| Gabapentin | 72 | $1,076 | $15 |
| Oxycodone-Acetaminophen | 19 | $963 | $51 |
| Morphine Sulfate Er | 39 | $927 | $24 |
| Methylphenidate | 33 | $918 | $28 |
| Hydrocodone-Acetaminophen | 19 | $596 | $31 |
| Methadone | 25 | $387 | $15 |
| Loperamide | 12 | $289 | $24 |
| Hydromorphone | 14 | $234 | $17 |
| Pregabalin | 20 | $215 | $11 |
| Lorazepam | 24 | $180 | $7 |
| Olanzapine | 11 | $118 | $11 |
| Omeprazole | 13 | $70 | $5 |
| Zolpidem | 13 | $11 | $1 |
Year by year
| 2024 | 653 | 75 | 49% (321) | 5% | $45,066 |
| 2023 | 662 | 101 | 46% (303) | 6% | $56,093 |
| 2022 | 377 | 66 | 43% (163) | 15% | $37,264 |
| 2021 | 287 | 64 | 39% (112) | None | $28,070 |
| 2020 | 414 | 39 | 42% (174) | None | $52,128 |
| 2019 | 275 | 34 | 45% (124) | 11% | $20,270 |
| 2018 | 74 | 21 | 43% (32) | 24% | $6,180 |
| 2017 | 210 | 63 | 28% (59) | 11% | $8,250 |
| 2016 | 81 | 30 | 15% (12) | None | $4,668 |
| 2015 | 314 | 44 | 5% (15) | None | $23,599 |
| 2014 | 186 | 40 | None | None | $12,074 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Buprenorphine | 43 | $14,786 | $344 |
| Oxycontin | 16 | $10,251 | $641 |
| Fentanyl | 26 | $6,556 | $252 |
| Morphine Sulfate Er | 53 | $3,156 | $60 |
| Duloxetine | 19 | $3,003 | $158 |
| Gabapentin | 79 | $2,396 | $30 |
| Oxycodone | 74 | $1,960 | $26 |
| Hydrocodone-Acetaminophen | 31 | $883 | $28 |
| Methylphenidate | 39 | $790 | $20 |
| Ibuprofen | 12 | $638 | $53 |
| Ondansetron | 21 | $544 | $26 |
| Oxycodone-Acetaminophen | 16 | $515 | $32 |
| Pregabalin | 18 | $474 | $26 |
| Hydromorphone | 13 | $429 | $33 |
| Methadone | 15 | $410 | $27 |
| Trazodone | 19 | $399 | $21 |
| Olanzapine | 13 | $377 | $29 |
| Lorazepam | 28 | $176 | $6 |
2022: 9 drugs
| Buprenorphine | 35 | $13,085 | $374 |
| Duloxetine | 13 | $2,196 | $169 |
| Gabapentin | 49 | $1,718 | $35 |
| Pregabalin | 15 | $1,316 | $88 |
| Oxycodone | 40 | $1,224 | $31 |
| Methylphenidate | 22 | $804 | $37 |
| Hydrocodone-Acetaminophen | 25 | $595 | $24 |
| Cyclobenzaprine | 11 | $333 | $30 |
| Methadone | 14 | $249 | $18 |
2021: 9 drugs
| Oxycontin | 13 | $8,983 | $691 |
| Lidocaine | 14 | $5,129 | $366 |
| Buprenorphine | 12 | $4,173 | $348 |
| Duloxetine | 13 | $1,825 | $140 |
| Fentanyl | 14 | $896 | $64 |
| Oxycodone | 25 | $739 | $30 |
| Pregabalin | 12 | $608 | $51 |
| Gabapentin | 27 | $482 | $18 |
| Hydrocodone-Acetaminophen | 18 | $381 | $21 |
2020: 15 drugs
| Oxycontin | 38 | $33,202 | $874 |
| Buprenorphine | 12 | $3,952 | $329 |
| Lidocaine | 21 | $3,123 | $149 |
| Oxycodone | 35 | $1,682 | $48 |
| Fentanyl | 14 | $929 | $66 |
| Mirtazapine | 13 | $719 | $55 |
| Gabapentin | 33 | $631 | $19 |
| Morphine Sulfate Er | 19 | $555 | $29 |
| Oxycodone-Acetaminophen | 12 | $528 | $44 |
| Ondansetron | 21 | $499 | $24 |
| Methadone | 17 | $311 | $18 |
| Hydrocodone-Acetaminophen | 17 | $265 | $16 |
| Duloxetine | 14 | $231 | $16 |
| Zolpidem | 12 | $100 | $8 |
| Omeprazole | 11 | $86 | $8 |
2019: 6 drugs
| Oxycontin | 12 | $4,248 | $354 |
| Fentanyl | 29 | $3,640 | $126 |
| Oxycodone | 44 | $1,212 | $28 |
| Ondansetron | 14 | $436 | $31 |
| Gabapentin | 19 | $278 | $15 |
| Duloxetine | 13 | $227 | $17 |
2017: 3 drugs
| Oxycodone | 13 | $625 | $48 |
| Mirtazapine | 15 | $560 | $37 |
| Methylphenidate | 11 | $256 | $23 |
2015: 4 drugs
| Atrovent Hfa | 11 | $2,875 | $261 |
| Levetiracetam | 11 | $444 | $40 |
| Atorvastatin | 20 | $296 | $15 |
| Ibuprofen | 12 | $128 | $11 |
2014: 3 drugs
| Levetiracetam | 21 | $1,395 | $66 |
| Warfarin | 18 | $274 | $15 |
| Ibuprofen | 14 | $105 | $8 |
Money from drug and device companies
$23 in 2019
A payment is not proof that care is biased.
| Hologic | Aptima Combo 2 | $23 | 1 payment
|
See the published payment
| Hologic | Meals · 2019-02-12 | Aptima Combo 2 | $23 |
Professional record
- NPI
- 1720409584
- Licence
- CA A128591California A128591: Current · expires 2027-05-31
- Trained
- Oregon Health Sciences University School of Medicine, 2012 · 14 years ago
- Group
- University of California San Francisco · UCSF Medical Group Business Services
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 2500 Alhambra Ave, Martinez, CA, 94553
- NPI first listed
- 2013-12-20
- NPI last updated
- 2016-09-22
This is when the NPI record was last certified, not a medical board exam.